Investor Presentaiton
Use Of Non-GAAP Information (Continued)
We operate our business as two reportable segments - Passenger and Medical.
Segment Flight Profit and Flight Margin - Flight Profit is calculated as revenue less cost of revenue excluding non-cash timing of ROU asset amortization. Cost of revenue consists
of flight costs paid to operators or aircraft and cars, landing fees and internal costs incurred in generating organ ground transportation revenue using the Company's owned cars.
Flight Margin is calculated as Flight Profit divided by revenue. Flight Profit and Flight Margin are measures that management uses to assess the performance of the business. Blade
believes that Flight Profit and Flight Margin provide a more accurate measure of the profitability of the Company's flight and ground operations, as they focus solely on the direct
costs associated with those operations.
Adjusted Unallocated Corporate Expenses - Blade defines Adjusted Unallocated Corporate Expenses as segment net loss attributable to our Corporate expenses and software
development operating segment less non-cash items or certain transactions that are not indicative of ongoing Company operating performance and / or items that management
does not believe are reflective of our ongoing core operations that cannot be allocated to either of our reporting segments.
BLADE AIR MOBILITY, INC.
SEGMENT INFORMATION: REVENUE, FLIGHT PROFIT, FLIGHT MARGIN, ADJUSTED EBITDA WITH RECONCILIATION TO
TOTAL ADJUSTED EBITDA
(in thousands except percentages, unaudited)
"
Passenger
Medical
Total Revenue
Passenger
Medical
Total Flight Profit
Passenger
Three Months Ended
September 30,
2023
2022
$
37,995 $ 25,503
$
33.447
71.442
$
20,219
45,722
$
9,410 $
6,094
$
6.169
15.579
3.172
$
9.266
Medical
Total Flight Margin
24.8 %
23.9 %
18.4 %
15.7 %
21.8 %
20.3 %
Passenger
$
2.777
$
1,472
Medical
3.346
1,495
Total Segment Adjusted EBITDA
6,123
2.967
Adjusted unallocated corporate expenses and software development
(5,336)
(7,515)
Total Adjusted EBITDA
$
787 $
(4,548)
BLADE
49
49View entire presentation